News | January 23, 2024
Granules India posts Q3 FY24 consolidated PAT at Rs. 125.65 Cr
Granules India has reported total income of Rs. 1156.23 crores during the period ended December 31, 2023
Granules India has reported total income of Rs. 1156.23 crores during the period ended December 31, 2023
Glenmark Life Sciences has reported total income of Rs. 574.49 crores during the period ended December 31, 2023
Denifanstat achieved statistically significant results on primary and multiple secondary endpoints in a 52-week clinical trial
Tatva Chintan Pharma Chem has reported total income of Rs. 85.41 crores during the period ended December 31, 2023
The PAI was conducted for two drug product applications (ANDAs) filed from this facility
The company has posted net profit of Rs.33.57 crores for the 9 Months period ended December 31, 2023
Lays Foundation Stone of 6 new facilities at AIIMS Bhopal and inaugurates a slew of facilities in Madhya Pradesh
Star Health's convenient claims process, valued added offerings like free telemedicine consultations with expert doctors
The survey data presented in “The State of the Biopharmaceutical Industry 2024” report reveals that N=21 (18%) of industry professionals were convinced that CGT will dominate as the most important trend in pharma next year
Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024
Subscribe To Our Newsletter & Stay Updated
